Results 111 to 120 of about 16,074 (250)
Topiramate inhibits adjuvant-induced chronic orofacial inflammatory allodynia in the rat
Frontiers in PharmacologyChronic orofacial pain disorders are common debilitating conditions, affecting the trigeminal system. Its underlying pathophysiological mechanisms are still unclear and the therapy is often unsatisfactory, therefore, preclinical models are crucial to ...
Violetta Mohos +16 more
doaj +1 more source
Sumatriptan Use in Patients With Migraine: In Response [PDF]
, 2002 Jennifer H. Lofland
openalex +1 more source
Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack
Acta Medica Iranica, 2015 Migraine is a common and incapacitating neurologic disorder manifesting with episodic moderate to a severe headache and other symptoms such as photophobia, phonophobia, nausea, and vomiting.
Fahmida Ghaderibarmi +2 more
doaj
Secondary cluster headache responsive to sumatriptan. [PDF]
, 1995 Phillip D. Cremer +2 more
openalex +1 more source
Preparation of effervescent tablets for sumatriptan succinate
, 2005 Medabalmi, MK
openalex +1 more source
CGRP nuovo bersaglio farmacologico per il trattamento dell'emicrania [PDF]
, 2016 In questo lavoro di tesi sono state discusse varie classi di farmaci per il trattamento dell’emicrania, dai primi utilizzati fino agli studi più recenti.
ANDALORO, RACHELE
core
Iranian Journal of Medical Sciences, 2014 Background: Sodium valproate (SV) has been approved for migraine prophylaxis and its intravenous form is used to treat acute migraine attacks. We compared the efficacy and safety of intravenous SV and subcutaneous Sumatriptan in managing acute migraine ...
Abolghasem Rahimdel +4 more
doaj
Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. [PDF]
, 1992 A. Van Hecken +5 more
openalex +1 more source
Consistency of Response to Sumatriptan/Naproxen Sodium in a Placebo-Controlled, Crossover Study [PDF]
, 2009 RB Lipton +6 more
openalex +1 more source